NeuShen Therapeutics
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Developing small molecule drugs for neurological and rare diseases with high unmet need.
NeuroscienceRare Disease
Technology Platform
A proprietary small molecule discovery platform focused on blood-brain barrier penetration and CNS target engagement.
Opportunities
Significant unmet medical need in neurodegenerative and rare neurological diseases could lead to premium pricing and partnership deals.
Risk Factors
High risk of failure inherent in CNS drug development, particularly in demonstrating clinical efficacy in complex disorders.
Competitive Landscape
Faces competition from both global neuroscience biotechs and large pharma companies re-entering the CNS space, with high barriers due to complex biology and clinical trial challenges.